
Healthcare stays in flux as Congress passed an omnibus spending bill this past Friday, March 23, funding the federal government through September 2018.
While many healthcare provisions made their way into the budget, including increased funding for the opioid epidemic, the National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC), there was no inclusion of a market stabilization bill for Affordable Care Act (ACA) marketplaces. The ACA stabilization package was introduced to attempt to drive down premium increases, which are expected to rise by about 30 percent in 2019 without stabilization measures.
Here are some top-line takeaways for healthcare within the $1.3 trillion omnibus spending bill:
ACCC is continuing to monitor how the most recent omnibus bill will affect cancer care providers and their patients. Stay tuned for updates as we continue to analyze this legislation.

Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
